Zymark Acquisition Would Enable Caliper Profitability By Year-End 2005
This article was originally published in The Gray Sheet
Executive Summary
Caliper's existing distribution channels with diagnostics and life sciences manufacturers such as Bio-Rad and Agilent will remain unaffected by the firm's $72.7 mil. cash and stock purchase of Zymark
You may also be interested in...
Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
Medtech Industry Favorite Wins Seat On Powerful House E&C Committee
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.
Source: 3 Former Obama US CMS Officials Being Considered To Lead Biden’s Medicare Agency
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: